These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28687706)

  • 1. Bone Regulates Browning and Energy Metabolism Through Mature Osteoblast/Osteocyte PPARγ Expression.
    Brun J; Berthou F; Trajkovski M; Maechler P; Foti M; Bonnet N
    Diabetes; 2017 Oct; 66(10):2541-2554. PubMed ID: 28687706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption.
    Stechschulte LA; Czernik PJ; Rotter ZC; Tausif FN; Corzo CA; Marciano DP; Asteian A; Zheng J; Bruning JB; Kamenecka TM; Rosen CJ; Griffin PR; Lecka-Czernik B
    EBioMedicine; 2016 Aug; 10():174-84. PubMed ID: 27422345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteocytes contribute
    Chougule A; Baroi S; Czernik PJ; Crowe E; Chang MR; Griffin PR; Lecka-Czernik B
    Front Endocrinol (Lausanne); 2023; 14():1145467. PubMed ID: 37181042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of bone morphogenetic protein-3b (BMP-3b) in adipose tissues protects against high-fat diet-induced obesity.
    Hino J; Nakatani M; Arai Y; Tsuchida K; Shirai M; Miyazato M; Kangawa K
    Int J Obes (Lond); 2017 Apr; 41(4):483-488. PubMed ID: 28104917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nervous System Expression of PPARγ and Mutant PPARγ Has Profound Effects on Metabolic Regulation and Brain Development.
    Stump M; Guo DF; Lu KT; Mukohda M; Cassell MD; Norris AW; Rahmouni K; Sigmund CD
    Endocrinology; 2016 Nov; 157(11):4266-4275. PubMed ID: 27575030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARG in osteocytes controls cell bioenergetics and systemic energy metabolism independently of sclerostin levels in circulation.
    Baroi S; Czernik PJ; Khan MP; Letson J; Crowe E; Chougule A; Griffin PR; Rosen CJ; Lecka-Czernik B
    Mol Metab; 2024 Oct; 88():102000. PubMed ID: 39074536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of Lrp5 Signaling in Osteoblasts Sensitizes Male Mice to Diet-Induced Disturbances in Glucose Metabolism.
    Kim SP; Frey JL; Li Z; Goh BC; Riddle RC
    Endocrinology; 2017 Nov; 158(11):3805-3816. PubMed ID: 28938444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/β-catenin signaling in osteoblasts regulates global energy metabolism.
    Yao Q; Yu C; Zhang X; Zhang K; Guo J; Song L
    Bone; 2017 Apr; 97():175-183. PubMed ID: 28126632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice.
    Cho SW; Yang JY; Her SJ; Choi HJ; Jung JY; Sun HJ; An JH; Cho HY; Kim SW; Park KS; Kim SY; Baek WY; Kim JE; Yim M; Shin CS
    J Bone Miner Res; 2011 Aug; 26(8):1939-52. PubMed ID: 21351141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α/β-Hydrolase Domain 6 Deletion Induces Adipose Browning and Prevents Obesity and Type 2 Diabetes.
    Zhao S; Mugabo Y; Ballentine G; Attane C; Iglesias J; Poursharifi P; Zhang D; Nguyen TA; Erb H; Prentki R; Peyot ML; Joly E; Tobin S; Fulton S; Brown JM; Madiraju SR; Prentki M
    Cell Rep; 2016 Mar; 14(12):2872-88. PubMed ID: 26997277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular retinol-binding protein type III is a PPARgamma target gene and plays a role in lipid metabolism.
    Zizola CF; Schwartz GJ; Vogel S
    Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1358-68. PubMed ID: 18840764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside Rg3 ameliorated HFD-induced hepatic steatosis through downregulation of STAT5-PPARγ.
    Lee JB; Yoon SJ; Lee SH; Lee MS; Jung H; Kim TD; Yoon SR; Choi I; Kim IS; Chung SW; Lee HG; Min JK; Park YJ
    J Endocrinol; 2017 Dec; 235(3):223-235. PubMed ID: 29042402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial agonist, telmisartan, maintains PPARγ serine 112 phosphorylation, and does not affect osteoblast differentiation and bone mass.
    Kolli V; Stechschulte LA; Dowling AR; Rahman S; Czernik PJ; Lecka-Czernik B
    PLoS One; 2014; 9(5):e96323. PubMed ID: 24810249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo.
    Lecka-Czernik B; Ackert-Bicknell C; Adamo ML; Marmolejos V; Churchill GA; Shockley KR; Reid IR; Grey A; Rosen CJ
    Endocrinology; 2007 Feb; 148(2):903-11. PubMed ID: 17122083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteocalcin: skeletal and extra-skeletal effects.
    Neve A; Corrado A; Cantatore FP
    J Cell Physiol; 2013 Jun; 228(6):1149-53. PubMed ID: 23139068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-Chain Fatty Acids Protect Against High-Fat Diet-Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation.
    den Besten G; Bleeker A; Gerding A; van Eunen K; Havinga R; van Dijk TH; Oosterveer MH; Jonker JW; Groen AK; Reijngoud DJ; Bakker BM
    Diabetes; 2015 Jul; 64(7):2398-408. PubMed ID: 25695945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic inhibition of PPARγ S112 phosphorylation reduces bone formation and stimulates marrow adipogenesis.
    Ge C; Zhao G; Li B; Li Y; Cawthorn WP; MacDougald OA; Franceschi RT
    Bone; 2018 Feb; 107():1-9. PubMed ID: 29107124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
    Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
    Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor gamma: the more the merrier?
    Argmann CA; Cock TA; Auwerx J
    Eur J Clin Invest; 2005 Feb; 35(2):82-92; discussion 80. PubMed ID: 15667578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geranylgeranyl pyrophosphate stimulates PPARγ expression and adipogenesis through the inhibition of osteoblast differentiation.
    Weivoda MM; Hohl RJ
    Bone; 2012 Feb; 50(2):467-76. PubMed ID: 22019459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.